Feb 21, 2022
The medical establishment attacks IVM once again
If you believe in good medical research, then you will only get disgusted by the newly published clinical study on IVM.
“The study findings do not support the use of ivermectin for patients with COVID-19,” researchers conclude in the paper published online today in JAMA Internal Medicine. This was said in MedPage Today, aimed at physicians.
Just one very big problem. None of the detailed findings given below have statistical significance. In the last column note that the P values are all above what is considered a good value for statistical significance, namely 0.05 or below. Even the main finding or end point or outcome, progression to severe disease, that was used shows no validity.
Even more important, several of the findings or outcomes are better for the IVM group, especially all cause mortality, patients who had mechanical ventilation, and patients admitted to ICU. Know this, not every randomized clinical study merits respect.
Another issue is whether the dosing for IVM was appropriate; it may have been too little for hospitalized patients with serious symptoms. And there is no indication that zinc was also used. Also, there is an indication that IVM use occurred after about 5 days when all protocols using IVM emphasize very early use after first symptoms. Note that this study was for hospitalized patients, while the use of IVM has mainly been promoted to keep people out of the hospital.
